Market Cap 425.18M
Revenue (ttm) 1.88B
Net Income (ttm) -534.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.49%
Debt to Equity Ratio 2.46
Volume 3,086,300
Avg Vol 2,793,508
Day's Range N/A - N/A
Shares Out 112.48M
Stochastic %K 100%
Beta 0.84
Analysts Strong Sell
Price Target $5.75

Company Profile

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggreg...

Industry: Health Information Services
Sector: Healthcare
Phone: 571 389 6000
Address:
1812 N. Moore Street, Suite 1705, Arlington, United States
XQuise
XQuise Jun. 4 at 8:59 PM
$EVH 🧠👈🏻
0 · Reply
PatBtmn
PatBtmn Jun. 4 at 8:27 PM
$EVH strong finish.
0 · Reply
WM24
WM24 Jun. 4 at 2:47 PM
$EVH what a roller coaster this stock is.
0 · Reply
TOMKiLA
TOMKiLA Jun. 4 at 1:49 PM
$EVH big contracts are coming soon! Let’s see the x2/3 ebitda growth
0 · Reply
Stonkey
Stonkey Jun. 3 at 3:48 PM
$EVH Hopeless POS never going anywhere....
1 · Reply
StockHunter75
StockHunter75 Jun. 1 at 10:30 PM
$EVH Bullish
0 · Reply
riedela
riedela Jun. 1 at 2:23 PM
$EVH Beats working 😀
0 · Reply
BPler
BPler May. 29 at 9:43 AM
Wish ​$ELV would comeback to make that +30 buyout offer $EVH, but stock value got destroyed after that reject. Look at the 5-year-chart, I turnaround is coming but slowly.
0 · Reply
PatBtmn
PatBtmn May. 28 at 5:50 PM
0 · Reply
TOMKiLA
TOMKiLA May. 28 at 9:20 AM
$EVH Let's remember that at this point, Evolent has only finalized two internal agreements with existing companies, and these two agreements have brought numbers like 4.5 million new members and $200 million in additional revenue by Q3 2026. Evolent will certainly have had new customers on its hands at the beginning of the year, and during Q2 2026, I expect many agreements, at least four, and between $300 and $350 million in revenue starting next year. Evolent technically has a world of customers to open up; it must announce $1 billion in new revenue each year if it wants to show profits and the path to concrete revenue reduction. It's no coincidence that Evolent Health itself has stated that it expects a major change during 2027 and 2028. If Evolent wants to see profits, it will inevitably have to sign $1.2–$1.5 billion in new deals and surprise everyone. Not easy, but I'd say more than possible!
0 · Reply
Latest News on EVH
Evolent Health price target raised to $5.50 from $4 at Citi

2026-05-15T10:52:20.000Z - 20 days ago

Evolent Health price target raised to $5.50 from $4 at Citi


Evolent Health price target raised to $6 from $5 at Canaccord

2026-05-12T11:20:59.000Z - 23 days ago

Evolent Health price target raised to $6 from $5 at Canaccord


Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)

2026-05-07T15:15:00.000Z - 4 weeks ago

Evolent Health reports Q1 adjusted EPS (2c), consensus (5c)


Evolent Health Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Evolent Health Earnings Call Transcript: Q1 2026


Evolent Health Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Evolent Health Earnings release: Q1 2026


Evolent Health Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Evolent Health Slides: Q1 2026


Evolent Health Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Evolent Health Quarterly report: Q1 2026


Evolent Announces First Quarter 2026 Results

May 7, 2026, 7:00 AM EDT - 4 weeks ago

Evolent Announces First Quarter 2026 Results


Evolent Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Evolent Health Proxy statement: Proxy filing


Evolent Health Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 5 weeks ago

Evolent Health Proxy statement: Proxy filing


Evolent Health appoints Archie Mayani as Chief Product Officer

2026-03-19T12:56:59.000Z - 2 months ago

Evolent Health appoints Archie Mayani as Chief Product Officer


Evolent to Participate in Upcoming Investor Conferences

Feb 26, 2026, 5:00 PM EST - 3 months ago

Evolent to Participate in Upcoming Investor Conferences


Evolent Health price target lowered to $5 from $10 at UBS

2026-02-26T13:16:53.000Z - 3 months ago

Evolent Health price target lowered to $5 from $10 at UBS


Evolent Health price target lowered to $4 from $6 at Citi

2026-02-26T11:37:03.000Z - 3 months ago

Evolent Health price target lowered to $4 from $6 at Citi


Evolent Health price target lowered to $6 from $10 at Truist

2026-02-25T18:25:33.000Z - 3 months ago

Evolent Health price target lowered to $6 from $10 at Truist


Evolent Health price target lowered to $8 from $10 at BTIG

2026-02-25T12:24:40.000Z - 3 months ago

Evolent Health price target lowered to $8 from $10 at BTIG


Evolent Health price target lowered to $4 from $9 at Canaccord

2026-02-25T11:57:07.000Z - 3 months ago

Evolent Health price target lowered to $4 from $9 at Canaccord


Evolent Health Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

Evolent Health Earnings Call Transcript: Q4 2025


Evolent Health Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

Evolent Health Annual report: Q4 2025


Evolent Health Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

Evolent Health Earnings release: Q4 2025


Evolent Health Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

Evolent Health Slides: Q4 2025


Evolent Health reports Q4 adjusted EPS 8c vs. (2c) last year

2026-02-24T21:20:38.000Z - 3 months ago

Evolent Health reports Q4 adjusted EPS 8c vs. (2c) last year


Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B

2026-02-24T21:18:28.000Z - 3 months ago

Evolent Health sees FY26 revenue $2.4B-$2.6B, consensus $2.38B


Evolent Health price target lowered to $10 from $16 at BTIG

2026-02-02T12:15:14.000Z - 4 months ago

Evolent Health price target lowered to $10 from $16 at BTIG


Evolent Health price target lowered to $6 from $9.50 at Citi

2026-01-09T12:15:58.000Z - 5 months ago

Evolent Health price target lowered to $6 from $9.50 at Citi


Evolent Health price target lowered to $10 from $11 at Citizens

2026-01-06T10:40:32.000Z - 5 months ago

Evolent Health price target lowered to $10 from $11 at Citizens


Evolent Health price target lowered to $7 from $13 at JPMorgan

2025-11-17T12:30:39.000Z - 7 months ago

Evolent Health price target lowered to $7 from $13 at JPMorgan


Evolent Health price target lowered to $9 from $16 at Canaccord

2025-11-14T11:26:02.000Z - 7 months ago

Evolent Health price target lowered to $9 from $16 at Canaccord


Evolent Health Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Evolent Health Earnings Call Transcript: Q3 2025


Evolent Health Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Evolent Health Quarterly report: Q3 2025


Evolent Health Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Evolent Health Earnings release: Q3 2025


Evolent Health Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 7 months ago

Evolent Health Slides: Q3 2025


Evolent Announces Third Quarter 2025 Results

Nov 6, 2025, 4:10 PM EST - 7 months ago

Evolent Announces Third Quarter 2025 Results


Evolent Health Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

Evolent Health Earnings Call Transcript: Q2 2025


Evolent Health Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

Evolent Health Quarterly report: Q2 2025


Evolent Health Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

Evolent Health Earnings release: Q2 2025


Evolent Health Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

Evolent Health Slides: Q2 2025


Evolent Announces Second Quarter 2025 Results

Aug 7, 2025, 4:10 PM EDT - 10 months ago

Evolent Announces Second Quarter 2025 Results


Evolent announces key appointments to leadership team

Jul 9, 2025, 8:00 AM EDT - 11 months ago

Evolent announces key appointments to leadership team


Evolent Health Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q1 2025


Evolent Health Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Quarterly report: Q1 2025


Evolent Health Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Earnings release: Q1 2025


Evolent Health Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

Evolent Health Slides: Q1 2025


Evolent Announces First Quarter 2025 Results

May 8, 2025, 4:10 PM EDT - 1 year ago

Evolent Announces First Quarter 2025 Results


Evolent Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Earnings Call Transcript: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q4 2024


Evolent Health Annual report: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Annual report: Q4 2024


Evolent Health Earnings release: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Earnings release: Q4 2024


Evolent Health Slides: Q4 2024

Feb 20, 2025, 5:00 PM EST - 1 year ago

Evolent Health Slides: Q4 2024


Evolent Announces Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:10 PM EST - 1 year ago

Evolent Announces Fourth Quarter and Full Year 2024 Results


Evolent Health Announces Changes to Board of Directors

Feb 4, 2025, 7:00 AM EST - 1 year ago

Evolent Health Announces Changes to Board of Directors


Evolent Health Earnings Call Transcript: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Earnings Call Transcript: Q3 2024


Evolent Health Quarterly report: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Quarterly report: Q3 2024


Evolent Health Earnings release: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Earnings release: Q3 2024


Evolent Health Slides: Q3 2024

Nov 7, 2024, 5:00 PM EST - 1 year ago

Evolent Health Slides: Q3 2024


Evolent Announces Third Quarter 2024 Results

Nov 7, 2024, 4:10 PM EST - 1 year ago

Evolent Announces Third Quarter 2024 Results


Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2

Oct 2, 2024, 12:08 PM EDT - 1 year ago

Evolent Health Inc (EVH) Stock Price Down 3.2% on Oct 2


Evolent Health Earnings Call Transcript: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Evolent Health Earnings Call Transcript: Q2 2024


Evolent Health Quarterly report: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Evolent Health Quarterly report: Q2 2024


Evolent Health Earnings release: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Evolent Health Earnings release: Q2 2024


Evolent Health Slides: Q2 2024

Aug 8, 2024, 5:00 PM EDT - 1 year ago

Evolent Health Slides: Q2 2024


Evolent Announces Second Quarter 2024 Results

Aug 8, 2024, 4:10 PM EDT - 1 year ago

Evolent Announces Second Quarter 2024 Results


Evolent Health Earnings Call Transcript: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q1 2024


Evolent Health Quarterly report: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Quarterly report: Q1 2024


Evolent Health Earnings release: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Earnings release: Q1 2024


Evolent Health Slides: Q1 2024

May 9, 2024, 5:00 PM EDT - 2 years ago

Evolent Health Slides: Q1 2024


Evolent Announces First Quarter 2024 Results

May 9, 2024, 4:10 PM EDT - 2 years ago

Evolent Announces First Quarter 2024 Results


Evolent Health Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Proxy statement: Proxy Filing

Apr 26, 2024, 8:00 AM EDT - 2 years ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Earnings Call Transcript: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Earnings Call Transcript: Q4 2023


Evolent Health Annual report: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Annual report: Q4 2023


Evolent Health Earnings release: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Earnings release: Q4 2023


Evolent Health Slides: Q4 2023

Feb 22, 2024, 5:00 PM EST - 2 years ago

Evolent Health Slides: Q4 2023


Evolent Announces Fourth Quarter and Full Year 2023 Results

Feb 22, 2024, 4:10 PM EST - 2 years ago

Evolent Announces Fourth Quarter and Full Year 2023 Results


Evolent Health Slides: FY 2024

Jan 9, 2024, 6:45 PM EST - 2 years ago

Evolent Health Slides: FY 2024


Evolent Health Earnings Call Transcript: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Evolent Health Earnings Call Transcript: Q3 2023


Evolent Health Quarterly report: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Evolent Health Quarterly report: Q3 2023


Evolent Health Earnings release: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Evolent Health Earnings release: Q3 2023


Evolent Health Slides: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

Evolent Health Slides: Q3 2023


Evolent Announces Third Quarter 2023 Results

Nov 2, 2023, 4:10 PM EDT - 2 years ago

Evolent Announces Third Quarter 2023 Results


Evolent Health to Participate in Upcoming Conferences

Aug 8, 2023, 5:00 PM EDT - 3 years ago

Evolent Health to Participate in Upcoming Conferences


Evolent Health Earnings Call Transcript: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q2 2023


Evolent Health Quarterly report: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Quarterly report: Q2 2023


Evolent Health Earnings release: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings release: Q2 2023


Evolent Health Slides: Q2 2023

Aug 2, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Slides: Q2 2023


Evolent Announces Second Quarter 2023 Results

Aug 2, 2023, 4:10 PM EDT - 3 years ago

Evolent Announces Second Quarter 2023 Results


Evolent welcomes Toyin Ajayi to its Board of Directors

Jul 26, 2023, 4:42 PM EDT - 3 years ago

Evolent welcomes Toyin Ajayi to its Board of Directors


Evolent Health Transcript: Investor Day 2023

May 23, 2023, 10:00 AM EDT - 3 years ago

Evolent Health Transcript: Investor Day 2023


Evolent Health Slides: FY 2023

May 23, 2023, 10:00 AM EDT - 3 years ago

Evolent Health Slides: FY 2023


Evolent Health Earnings Call Transcript: Q1 2023

May 3, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings Call Transcript: Q1 2023


Evolent Health Quarterly report: Q1 2023

May 3, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Quarterly report: Q1 2023


Evolent Health Earnings release: Q1 2023

May 3, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Earnings release: Q1 2023


Evolent Health Slides: Q1 2023

May 3, 2023, 5:00 PM EDT - 3 years ago

Evolent Health Slides: Q1 2023


Evolent Health Announces First Quarter 2023 Results

May 3, 2023, 4:10 PM EDT - 3 years ago

Evolent Health Announces First Quarter 2023 Results


Evolent Health Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Evolent Health Proxy statement: Proxy Filing


Evolent Health Proxy statement: Proxy Filing

Apr 28, 2023, 8:00 AM EDT - 3 years ago

Evolent Health Proxy statement: Proxy Filing


XQuise
XQuise Jun. 4 at 8:59 PM
$EVH 🧠👈🏻
0 · Reply
PatBtmn
PatBtmn Jun. 4 at 8:27 PM
$EVH strong finish.
0 · Reply
WM24
WM24 Jun. 4 at 2:47 PM
$EVH what a roller coaster this stock is.
0 · Reply
TOMKiLA
TOMKiLA Jun. 4 at 1:49 PM
$EVH big contracts are coming soon! Let’s see the x2/3 ebitda growth
0 · Reply
Stonkey
Stonkey Jun. 3 at 3:48 PM
$EVH Hopeless POS never going anywhere....
1 · Reply
StockHunter75
StockHunter75 Jun. 1 at 10:30 PM
$EVH Bullish
0 · Reply
riedela
riedela Jun. 1 at 2:23 PM
$EVH Beats working 😀
0 · Reply
BPler
BPler May. 29 at 9:43 AM
Wish ​$ELV would comeback to make that +30 buyout offer $EVH, but stock value got destroyed after that reject. Look at the 5-year-chart, I turnaround is coming but slowly.
0 · Reply
PatBtmn
PatBtmn May. 28 at 5:50 PM
0 · Reply
TOMKiLA
TOMKiLA May. 28 at 9:20 AM
$EVH Let's remember that at this point, Evolent has only finalized two internal agreements with existing companies, and these two agreements have brought numbers like 4.5 million new members and $200 million in additional revenue by Q3 2026. Evolent will certainly have had new customers on its hands at the beginning of the year, and during Q2 2026, I expect many agreements, at least four, and between $300 and $350 million in revenue starting next year. Evolent technically has a world of customers to open up; it must announce $1 billion in new revenue each year if it wants to show profits and the path to concrete revenue reduction. It's no coincidence that Evolent Health itself has stated that it expects a major change during 2027 and 2028. If Evolent wants to see profits, it will inevitably have to sign $1.2–$1.5 billion in new deals and surprise everyone. Not easy, but I'd say more than possible!
0 · Reply
Stonkey
Stonkey May. 27 at 7:51 PM
$EVH When CH11?
0 · Reply
riedela
riedela May. 27 at 7:18 PM
$EVH reloading 😏
0 · Reply
Stonkey
Stonkey May. 26 at 5:53 PM
$EVH When CH11?
0 · Reply
BPler
BPler May. 26 at 1:54 PM
$EVH Enjoying the discounts to average down and accumalte
0 · Reply
PatBtmn
PatBtmn May. 25 at 2:05 AM
1 · Reply
BPler
BPler May. 19 at 5:47 PM
$EVH Make it a +30 stock again.
0 · Reply
TOMKiLA
TOMKiLA May. 19 at 1:03 PM
$EVH The U.S. oncology market generated roughly \(\$145.52\) billion in revenue recently and is projected to surpass \(\$400\) billion by 2034, growing at a compound annual growth rate (CAGR) of \(11.1\%\). The sector remains the highest-grossing therapeutic area in pharmaceuticals, driving over \(\$110\) billion in annual sales among leading therapies Evolent (formerly New Century Health) is an oncology quality management and technology platform. It partners with health plans and providers to ensure cancer and radiation treatments follow evidence-based guidelines and utilize precision medicine See u over $2B within 12 months
0 · Reply
TOMKiLA
TOMKiLA May. 19 at 11:18 AM
$EVH don’t lose the hope, evolent will run quickly this year, the road to 10$ is closer and closer
0 · Reply
prismmarketview
prismmarketview May. 18 at 2:34 PM
Agentic AI = AI agents that can plan and execute tasks end‑to‑end. In healthcare, that means automating intake, documentation, and claims—one reason AI‑exposed health names are getting more attention. UiPath Inc. (NYSE: $PATH) SoundHound AI (NASDAQ: $SOUN), Evolent Health (NYSE: $EVH), C3 AI (NYSE: $AI), #AI #Healthcare #AgenticAI #Stocks https://prismmarketview.com/agentic-ai-ignites-a-new-rally-in-u-s-healthcare-stocks/
0 · Reply
WM24
WM24 May. 18 at 3:14 AM
$EVH wondering if UNH will drag EVH down tomorrow….
0 · Reply
PatBtmn
PatBtmn May. 15 at 5:00 PM
$EVH don’t
0 · Reply
riedela
riedela May. 15 at 2:25 PM
$EVH 💪 looks like we are finally over the abuse. Congrats Longs
1 · Reply